Brenig Therapeutics is a startup based in Israel, 2 tracked investors.
Brenig Therapeutics is a company founded in 2021 headquartered in Israel. Brouky records 2 investors associated with the company.
Brenig Therapeutics develops highly selective small-molecule therapies targeting neurodegenerative diseases, with a focus on Parkinson's disease through brain-penetrant inhibitors of LRRK2 and NLRP3 inflammasome pathways.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.